Christopher Gibson, MD, is a pediatric endocrinologist in the Division of Endocrinology and Diabetes at Children's Hospital of Philadelphia.
Areas of Expertise:
Disorders of puberty, Disorders of sexual development, Pediatric fertility, Pituitary disorders, Late endocrine effects of cancer therapy in children Locations:Specialty Care, King of Prussia
Dr. Gibson is a native of northern New Jersey. He completed his undergraduate at the University of Michigan, and medical school at the Creighton University School of Medicine in Omaha, NE. He completed his pediatric training at St. Christopher’s Hospital for Children in Philadelphia, and his pediatric endocrine training at The Children’s Hospital of Philadelphia (CHOP).
Dr. Gibson is currently a board-certified pediatric Endocrinologist in the Division of Endocrinology and Diabetes at Children's Hospital of Philadelphia. His interests include pubertal disorders (early or delayed), differences in sex development (DSD), and Endocrine late effects in survivors of childhood cancer. Dr Gibson is also involved in the CHOP NeuroEndocrine Center, as well as the Congenital Hyperinsulinism and Diabetes Centers. He is a member of the Diabetes consult service, providing consultations for hospitalized children with specialized forms of diabetes (cystic fibrosis related diabetes, steroid induced hyperglycemia, and monogenic forms of diabetes).
Education and Training
MD - Creighton University School of Medicine, Omaha, NE
Pediatrics - St. Christopher’s Hospital for Children, Philadelphia, PA
Pediatric Endocrinology - The Children's Hospital of Philadelphia, Philadelphia, PA
Endocrinology, Diabetes and Metabolism – American Board of Internal MedicinePediatrics – American Board of Pediatrics
Titles and Academic Titles
Assistant Professor of Clinical Pediatrics, Division of Endocrinology, The Perelman School of Medicine at the University of Pennsylvania
Gibson CE, Boodhansingh KE, Li C, Conlin L, Chen P, Becker S, Adzick NS, Bamba V, De Leon DD, Ganguly A, Stanley CA: Congenital hyperinsulinism in Infants with Turner Syndrome: Possible association with Monosomy X and KDM6A haploinsufficiency. Hormone Research in Pediatrics 89:413-422, 2018.
Gibson CE and Gracia CR. “Influence of Oral Contraceptives on Serum AMH” in Anti-Mullerian Hormone: Biology, Role in Ovarian Function, and Clinical Significance. Editors: Seifer DB, Reshef T. Nova Science Publishing. October 2015.
Gibson, CE, Alter CA: Hypophysitis. Diabetes Insipidus in Children: A Pocket Guide. Springer International Publishing, Sept 2021.
Posters and Presentations
Gibson CE, Boodhansingh KE, Ganguly A, Stanley CA. “Congenital Hyperinsulinism in Turner Syndrome.” Poster Presentation. Endocrine Society Annual Meeting. San Diego, CA, March 2015.
Gibson CE, Langdon D. A Novel Mutation in a Blepharophimosis ptosis epicanthus inversus syndrome patient presenting with primary amenorrhea. Poster Presentation. Pediatric Academic Societies Annual Meeting. Vancouver, Canada, May 2014.
Endocrine Evaluations in Thalassemia Patients. Oral Presentation. Children’s Hospital of Philadelphia Division of Hematology, Annual Parent and Family Thalassemia Meeting. May 2014.
Gibson CE: Call the Doctor, Obesity and Diabetes. Panelist - WVIA Television Network, Northeastern and Central Pennsylvania Public Broadcasting Station April 2016.
Awards and Honors
2021, CHOP Faculty Honor Roll
2014, Pediatric Endocrine Society Travel Grant Award, Vancouver, Canada
Leadership and Memberships
Memberships in professional organizations
Pediatric Endocrine Society
Philadelphia Endocrine Society
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.